Ascendis Pharma A
Officers & Directors
Jan Møller Mikkelsen serves as President, Chief Executive Officer, and Board Member, participating on both the board of directors and the executive board. Albert Cha, M.D., Ph.D., has been Chairman and Board Member since May 2021 and a board member since November 2014. He is a Managing Partner at Frazier Life Sciences and has held various roles at Vivo Capital LLC. He has served on the boards of KalVista Pharmaceuticals, Inc., Aclaris Therapeutics, Sierra Oncology, Inc., Biohaven Pharmaceutical Holding Company Ltd, and Menlo Therapeutics, Inc. Lisa Bright has been a Board Member since April 2017 and has over 30 years of executive experience in global life sciences companies. She serves on the board of Immedica Pharma AB, chairs Metadeq Inc and DRI Capital, and is an Executive Partner at Syncona Limited. Her previous leadership roles include positions at Intercept Pharmaceuticals, Inc., Gilead Sciences Ltd., GlaxoSmithKline plc, and Sanofi. William Carl Fairey Jr. has been a Board Member since September 2022; further details about his background are not provided.
Ascendis Pharma A currently has 100 employees.
|
